Basics Acumen Pharmaceuticals, Inc. IPO Date: July 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $60.57M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 3.70% Avg Daily Range (30 D): $0.04 | 3.40% Avg Daily Range (90 D): $0.04 | 3.77% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 163 Avg Trade Size (Sh.) (90 D): 160 Institutional Trades Total Inst.Trades: 56 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.68M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.29M Avg Closing Trade (30 D): $8.78M Avg Closing Trade (90 D): $8.78M Avg Closing Volume: 525.35K     News May 7, 2025 @ 8:00 PM Acumen Pharmaceuticals to Participate in the Bank ... Source: N/A May 6, 2025 @ 8:00 PM Acumen Pharmaceuticals to Report First Quarter 202... Source: N/A Apr 2, 2025 @ 11:00 AM Acumen Pharmaceuticals Showcases pTau217 Trial Scr... Source: N/A Mar 19, 2025 @ 11:00 AM Chlorinated Isopropane Market Set for 4.9% CAGR Gr... Source: Fact.Mr Mar 12, 2025 @ 12:00 PM Acumen Pharmaceuticals to Present During Internati... Source: Acumen Pharmaceuticals, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.48 $-.62 $-1.71 Diluted EPS $-.48 $-.62 $-1.71 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -28.8M $ -37.15M $ -102.33M Operating Income / Loss $ -30.37M $ -39.6M $ -114.02M Cost of Revenue $ $ $ Net Cash Flow $ -5.47M $ 2.44M $ -31.26M PE Ratio